Disease progression was more likely to be the best response to immunotherapy for patients with hepatocellular carcinoma (HCC) and cirrhosis due to nonalcoholic fatty liver disease (NAFLD). The ...

A multi-omics blood assay, HCCscreen, demonstrated superior performance for detecting hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis compared with individual bi ...

Please provide your email address to receive an email when new articles are posted on . The 5-year cumulative incidences of HCC and liver-related events were 3.8% and 15.6%, respectively. Incidences ...

Please provide your email address to receive an email when new articles are posted on . In the era of direct-acting antivirals, rates of hepatocellular carcinoma are rising in patients without ...

Clinicians in 5 states participated in an online survey to gauge the level of compliance with HCC surveillance guidelines. According to the survey, knowledge gaps and barriers to HCC screening in ...

SAN DIEGO — In patients with metabolic dysfunction–associated steatotic liver disease (MASLD), hypertension, and cirrhosis, certain antihypertensive medications may lead to increased risks for ...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving patient outcomes and offers the best chance for curative treatment, making HCC screening a vital strategy for high-risk ...

Liver cirrhosis, the common endpoint of chronic liver disease, is characterized by diffuse fibrosis, pseudolobule formation, and vascular distortion. Its clinical spectrum ranges from asymptomatic ...

Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...